Glycoprotein Ib (GPIb)-dependent and GPIb-independent pathways of thrombin-induced platelet activation

Abstract

In this study, the question of whether glycoprotein Ib (GPIb) mediates both high and moderate affinity pathways of α-thrombin-induced platelet activation was examined. Flow cytometric studies, using a panel of monoclonal antibodies (MoAbs), showed that Serratia marcescens protease treatment removed greater than 97% of the glycocalicin portion of GPIb but did not affect the changes in the expression of GPIX or GMP-140 that were induced by high concentrations of α-thrombin (10 nmol/L). However, Serratia treatment almost completely abolished the increase in platelet surface GMP-140 induced by low concentrations of α-thrombin (0.5 nmol/L) and diminished the downregulation of platelet surface GPIX by 60.9% ± 5.6% (mean ± SEM, n = 3). When present in 20-fold molar excess, an MoAb directed against the α-thrombin/von Willebrand factor (vWf) binding domains of GPIb completely blocked the ristocetin-dependent binding of vWf to platelets but inhibited only to about 50% the binding of α-thrombin and the activation-dependent binding of vWf. In platelets treated with Serratia marcescens protease to remove GPIb, a concentration of this MoAb 16,000-fold in excess of the maximum possible remaining copies of GPIb failed to inhibit platelet activation by α-thrombin. These studies demonstrate that activation of intact platelets by α-thrombin proceeds by both GPIb-dependent and GPIb-independent mechanisms. © 1991 by The American Society of Hematology.